Surfactant therapy for acute respiratory failure in children: A systematic review and meta-analysis

Critical Care

Volumn 11, Issue , 2007, Pages

  Duffett, Mark ^a   Choong, Karen ^a   Ng, Vivian ^b   Randolph, Adrienne ^c   Cook, Deborah J ^d  

^a MCMASTER CHILDREN S HOSPITAL   (Canada)

^b GRAND RIVER HOSPITAL   (Canada)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; BERACTANT; CALFACTANT; LUNG SURFACTANT; PLACEBO; PORACTANT;

ACUTE RESPIRATORY FAILURE; ARTIFICIAL VENTILATION; BRONCHIOLITIS; BRONCHOSPASM; CHILD; CHILDHOOD MORTALITY; CINAHL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; EMBASE; ENDOTRACHEAL INTUBATION; HEMODYNAMICS; HOSPITAL INFECTION; HUMAN; HYPOTENSION; HYPOXIA; LENGTH OF STAY; LUNG EMPHYSEMA; MEDLINE; META ANALYSIS; NEAR DROWNING; NEBULIZATION; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; QUANTITATIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; SEPSIS; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; ADULT RESPIRATORY DISTRESS SYNDROME; COMPARATIVE STUDY; INTENSIVE CARE; MORTALITY; STATISTICS; SURVIVAL;

CHILD; HUMANS; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84922594516     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5944     Document Type: Review

References (28)

1. Randolph AG Meert KL O'Neil ME Hanson JH Luckett PM Arnold JH Gedeit RG Cox PN Roberts JS Venkataraman ST The feasibility of conducting clinical trials in infants and children with acute respiratory failure Am J Respir Crit Care Med 2003 167 1334-1340 10.1164/rccm.200210-1175OC 12615617
2. Royall JA Levin DL Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury J Pediatr 1988 112 169-180 10.1016/ S0022-3476(88)80053-2 3276861
3. Skelton R Holland P Darowski M Chetcuti PA Morgan LW Harwood JL Abnormal surfactant composition and activity in severe bronchiolitis Acta Paediatr 1999 88 942-946 10.1080/08035259950168414 10519333
4. Dargaville PA South M McDougall PN Surfactant abnormalities in infants with severe viral bronchiolitis Arch Dis Child 1996 75 133-136 8869194
5. Long W Corbet A Cotton R Courtney S McGuiness G Walter D Watts J Smyth J Bard H Chernick V A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group N Engl J Med 1991 325 1696-1703 1944470
6. Anzueto A Baughman RP Guntupalli KK Weg JG Wiedemann HP Raventos AA Lemaire F Long W Zaccardelli DS Pattishall EN Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group N Engl J Med 1996 334 1417-1421 10.1056/NEJM199605303342201 8618579
7. Gregory TJ Steinberg KP Spragg R Gadek JE Hyers TM Longmore WJ Moxley MA Cai GZ Hite RD Smith RM Bovine surfactant therapy for patients with acute respiratory distress syndrome Am J Respir Crit Care Med 1997 155 1309-1315 9105072
8. Spragg RG Lewis JF Wurst W Hafner D Baughman RP Wewers MD Marsh JJ Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant Am J Respir Crit Care Med 2003 167 1562-1566 10.1164/rccm.200207-782OC 12649125
9. Weg JG Balk RA Tharratt RS Jenkinson SG Shah JB Zaccardelli D Horton J Pattishall EN Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome JAMA 1994 272 1433-1438 10.1001/jama.272.18.1433 7933425
10. Lewis JF Dhillon JS Singh RN Johnson CC Frewen TC Exogenous surfactant therapy for pediatric patients with the acute respiratory distress syndrome Can Respir J 1997 4 21-26
11. Willson DF Jin Hua J Bauman LA Zaritsky A Craft H Dockery K Conrad D Dalton H Calf's lung surfactant extract in acute hypoxemic respiratory failure in children Crit Care Med 1996 24 1316-1322 10.1097/ 00003246-199608000-00008 8706485
12. Willson DF Thomas NJ Markovitz BP Bauman LA DiCarlo JV Pon S Jacobs BR Jefferson LS Conaway MR Egan EA Effect of exogenous surfactant (calfactant) in pediatric acute lung injury: A randomized controlled trial JAMA 2005 293 470-476 10.1001/jama.293.4.470 15671432
13. Moller JC Schaible T Roll C Schiffmann JH Bindl L Schrod L Reiss I Kohl M Demirakca S Hentschel R Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: A randomized multicenter study Intensive Care Med 2003 29 437-446 12589529
14. Davison C Ventre KM Luchetti M Randolph AG Efficacy of interventions for bronchiolitis in critically ill infants: A systematic review and meta-analysis Pediatr Crit Care Med 2004 5 482-489 10.1097/ 01.PCC.0000128891.54799.67 15329166
15. Schoenfeld DA Bernard GR Network A Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome Crit Care Med 2002 30 1772-1777 10.1097/00003246-200208000-00016 12163791
16. Fleiss JL The statistical basis of meta-analysis Stat Methods Med Res 1993 2 121-145 8261254
17. Higgins JPT Thompson SG Quantifying heterogeneity in a meta-analysis Stat Med 2002 21 1539-1558 10.1002/sim.1186 12111919
18. RevMan Analyses 1.0 for Windows in Review Manager [RevMan] 4.2 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration 2003
19. DerSimonian R Laird N Meta-analysis in clinical trials Control Clin Trials 1986 7 177-188 10.1016/0197-2456(86)90046-2 3802833
20. Tibby SM Hatherill M Wright SM Wilson P Postle AD Murdoch IA Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis Am J Respir Crit Care Med 2000 162 1251-1256 11029326
21. Luchetti M Ferrero F Gallini C Natale A Pigna A Tortorolo L Marraro G Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure Pediatr Crit Care Med 2002 3 261-268 10.1097/00130478-200207000-00011 12780967
22. Luchetti M Casiraghi G Valsecchi R Galassini E Marraro G Porcine-derived surfactant treatment of severe bronchiolitis Acta Anaesthesiol Scand 1998 42 805-810 9698957
23. Willson DF Zaritsky A Bauman LA Dockery K James RL Conrad D Craft H Novotny WE Egan EA Dalton H Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure Crit Care Med 1999 27 188-195 10.1097/00003246-199901000-00050 9934915
24. Moller JC Schaible T Roll C Schiffmann JH Bindl L Schrod L Reiss I Kohl M Demirakca S Hentschel R Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: A randomized multicenter study Intensive Care Med 2003 29 437-446 12589529
25. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 2000 342 1301-1308 10.1056/NEJM200005043421801 10793162
26. Arnold JH Anas NG Luckett P Cheifetz IM Reyes G Newth CJ Kocis KC Heidemann SM Hanson JH Brogan TV Bohn DJ High-frequency oscillatory ventilation in pediatric respiratory failure: A multicenter experience Crit Care Med 2000 28 3913-3919 10.1097/00003246-200012000-00031 11153635
27. Arnold JH Hanson JH Toro-Figuero LO Gutierrez J Berens RJ Anglin DL Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure Crit Care Med 1994 22 1530-1539 7924362
28. Curley MA Zimmerman JJ Alternative outcome measures for pediatric clinical sepsis trials Pediatr Crit Care Med 2005 6 S150-S156 10.1097/ 01.PCC.0000161582.63265.B6 15857550